 KEPPRA
|
GlaxoSmithKline Biopharma
|
| levetiracetam |
Antiepiléptico |
| 1000 mg comp.x 30 | $157.802,50 | (28/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $77.505,85 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $109.807,49 |
|
|
|
|
| 1000 mg comp.x 60 | $214.251,86 | (28/02/25) |
| Importado |
| PAMI |
|
| AF $83.912,29 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $137.744,59 |
|
|
|
|
| 500 mg comp.x 20 | $65.824,14 | (28/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.941,63 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $29.990,26 AF $35.833,88 |
|
|
|
|
| 500 mg comp.x 30 | $75.048,23 | (28/02/25) |
| Importado |
| PAMI |
|
| AF $30.168,46 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $27.053,22 |
|
|
|
|
| 500 mg comp.x 60 | $147.932,00 | (28/02/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $72.657,88 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $71.424,73 |
|
|
|
|
| sol.oral x 300 ml | $197.125,92 | (28/02/25) |
| Importado |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $83.091,87 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $92.837,80 AF $104.288,12 |
|
|
|
|
| |
